114 related articles for article (PubMed ID: 27655663)
1. Locked nucleic acid-inhibitor of miR-205 decreases endometrial cancer cells proliferation in vitro and in vivo.
Torres A; Kozak J; Korolczuk A; Rycak D; Wdowiak P; Maciejewski R; Torres K
Oncotarget; 2016 Nov; 7(45):73651-73663. PubMed ID: 27655663
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo activity of miR-92a-Locked Nucleic Acid (LNA)-Inhibitor against endometrial cancer.
Torres A; Kozak J; Korolczuk A; Wdowiak P; Domańska-Glonek E; Maciejewski R; Torres K
BMC Cancer; 2016 Oct; 16(1):822. PubMed ID: 27782822
[TBL] [Abstract][Full Text] [Related]
3. Locked nucleic acid anti-miR-21 inhibits cell growth and invasive behaviors of a colorectal adenocarcinoma cell line: LNA-anti-miR as a novel approach.
Nedaeinia R; Sharifi M; Avan A; Kazemi M; Rafiee L; Ghayour-Mobarhan M; Salehi R
Cancer Gene Ther; 2016 Aug; 23(8):246-53. PubMed ID: 27364574
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-505 functions as a tumor suppressor in endometrial cancer by targeting TGF-α.
Chen S; Sun KX; Liu BL; Zong ZH; Zhao Y
Mol Cancer; 2016 Feb; 15():11. PubMed ID: 26832151
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo activity of a novel locked nucleic acid (LNA)-inhibitor-miR-221 against multiple myeloma cells.
Di Martino MT; Gullà A; Gallo Cantafio ME; Altomare E; Amodio N; Leone E; Morelli E; Lio SG; Caracciolo D; Rossi M; Frandsen NM; Tagliaferri P; Tassone P
PLoS One; 2014; 9(2):e89659. PubMed ID: 24586944
[TBL] [Abstract][Full Text] [Related]
6. miR-205 inhibits cell growth by targeting AKT-mTOR signaling in progesterone-resistant endometrial cancer Ishikawa cells.
Zhuo Z; Yu H
Oncotarget; 2017 Apr; 8(17):28042-28051. PubMed ID: 28427207
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-503 suppresses proliferation and cell-cycle progression of endometrioid endometrial cancer by negatively regulating cyclin D1.
Xu YY; Wu HJ; Ma HD; Xu LP; Huo Y; Yin LR
FEBS J; 2013 Aug; 280(16):3768-79. PubMed ID: 23731275
[TBL] [Abstract][Full Text] [Related]
8. miR-944 acts as a prognostic marker and promotes the tumor progression in endometrial cancer.
He Z; Xu H; Meng Y; Kuang Y
Biomed Pharmacother; 2017 Apr; 88():902-910. PubMed ID: 28178620
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological Inhibition of miR-130 Family Suppresses Bladder Tumor Growth by Targeting Various Oncogenic Pathways via PTPN1.
Monoe Y; Jingushi K; Kawase A; Hirono T; Hirose R; Nakatsuji Y; Kitae K; Ueda Y; Hase H; Abe Y; Adachi J; Tomonaga T; Tsujikawa K
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33947152
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA miR-302 inhibits the tumorigenicity of endometrial cancer cells by suppression of Cyclin D1 and CDK1.
Yan GJ; Yu F; Wang B; Zhou HJ; Ge QY; Su J; Hu YL; Sun HX; Ding LJ
Cancer Lett; 2014 Apr; 345(1):39-47. PubMed ID: 24333727
[TBL] [Abstract][Full Text] [Related]
11. miR-152 inhibits proliferation of human endometrial cancer cells via inducing G2/M phase arrest by suppressing CDC25B expression.
Xie D; Liang Y; Su Y; An Y; Qu P
Biomed Pharmacother; 2018 Mar; 99():299-305. PubMed ID: 29353204
[TBL] [Abstract][Full Text] [Related]
12. Effect of the molecular targeted drug, erlotinib, against endometrial cancer expressing high levels of epidermal growth factor receptor.
Nishimura T; Nakamura K; Yamashita S; Ikeda S; Kigure K; Minegishi T
BMC Cancer; 2015 Dec; 15():957. PubMed ID: 26673416
[TBL] [Abstract][Full Text] [Related]
13. The interactions between MicroRNA-200c and BRD7 in endometrial carcinoma.
Park YA; Lee JW; Choi JJ; Jeon HK; Cho Y; Choi C; Kim TJ; Lee NW; Kim BG; Bae DS
Gynecol Oncol; 2012 Jan; 124(1):125-33. PubMed ID: 22015043
[TBL] [Abstract][Full Text] [Related]
14. MiR-449a functions as a tumor suppressor in endometrial cancer by targeting CDC25A.
Ye W; Xue J; Zhang Q; Li F; Zhang W; Chen H; Huang Y; Zheng F
Oncol Rep; 2014 Sep; 32(3):1193-9. PubMed ID: 24993091
[TBL] [Abstract][Full Text] [Related]
15. Silencing of ghrelin receptor expression inhibits endometrial cancer cell growth in vitro and in vivo.
Fung JN; Jeffery PL; Lee JD; Seim I; Roche D; Obermair A; Chopin LK; Chen C
Am J Physiol Endocrinol Metab; 2013 Jul; 305(2):E305-13. PubMed ID: 23736537
[TBL] [Abstract][Full Text] [Related]
16. Exploration of miR-1202 and miR-196a in human endometrial cancer based on high throughout gene screening analysis.
Chen H; Fan Y; Xu W; Chen J; Meng Y; Fang D; Wang J
Oncol Rep; 2017 Jun; 37(6):3493-3501. PubMed ID: 28440476
[TBL] [Abstract][Full Text] [Related]
17. Progesterone-Induced miR-152 Inhibits the Proliferation of Endometrial Epithelial Cells by Downregulating WNT-1.
Nie L; Zhao YB; Pan JL; Lei Y; Liu M; Long Y; Zhang JH; Hu Y; Xu MQ; Yuan DZ; Yue LM
Reprod Sci; 2017 Oct; 24(10):1444-1453. PubMed ID: 28122483
[TBL] [Abstract][Full Text] [Related]
18. miR-10b Inhibits Apoptosis and Promotes Proliferation and Invasion of Endometrial Cancer Cells via Targeting HOXB3.
Chen H; Fan Y; Xu W; Chen J; Xu C; Wei X; Fang D; Feng Y
Cancer Biother Radiopharm; 2016 Aug; 31(6):225-31. PubMed ID: 27447302
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-372 inhibits endometrial carcinoma development by targeting the expression of the Ras homolog gene family member C (RhoC).
Liu BL; Sun KX; Zong ZH; Chen S; Zhao Y
Oncotarget; 2016 Feb; 7(6):6649-64. PubMed ID: 26673619
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-424 may function as a tumor suppressor in endometrial carcinoma cells by targeting E2F7.
Li Q; Qiu XM; Li QH; Wang XY; Li L; Xu M; Dong M; Xiao YB
Oncol Rep; 2015 May; 33(5):2354-60. PubMed ID: 25708247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
